CRT-100.01 Risk-Stratifying Patients With Cardiogenic Shock: An Analysis of the Multicenter Cardiogenic Shock Working Group Registry

Cardiogenic shock (CS) mortality remains unacceptably high. Risk-stratifying CS patients could improve case management and the design of future trials. Using real-world data, we tested whether the Society for Cardiovascular Angiography and Interventions (SCAI) CS Stages, drug and device escalation,